Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Llp Abingworth currently holds 1,066,189 shares of Jasper Therapeutics, Inc. (JSPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Llp Abingworth has been a net seller of JSPR stock. They have purchased $44.0M and sold $240.5M worth of shares.
Llp Abingworth's most recent insider trade was on Feb 8, 2024, when they purchased 190,000 shares at $12.95 per share.
Llp Abingworth serves as Executive at Jasper Therapeutics, Inc. (JSPR). They have executed 45 insider transactions totaling $284.5M over their tenure at the company.
Llp Abingworth holds the position of Executive at Jasper Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Llp Abingworth has shown a selling trading pattern, with $44.0M in total purchases and $240.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Llp Abingworth was on Apr 18, 2011, when they sold $62.1M worth of AMRN shares. This transaction involved 4,179,174 shares at $14.87 per share.
Llp Abingworth currently owns 1,066,189 shares of Jasper Therapeutics, Inc. (JSPR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Llp Abingworth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Llp Abingworth has 45 Form 4 filings on record as an insider at Jasper Therapeutics, Inc..
Set alerts for Llp Abingworth and 40,000+ other insiders.